Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EIF3L | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | DPH5 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | PARP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | LGALS3 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | TBX1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | SCML2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | MSI1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | HIRA | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | HAUS6 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
mRNA | LAMP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |